Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of this study was to evaluate the effect of DID on the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Ha, Hyerim, Keam, Bhumsuk, Kim, Tae Min, Jeon, Yoon Kyung, Lee, Se-Hoon, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720063/
https://ncbi.nlm.nih.gov/pubmed/25865654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados